Dongmin Chang

816 total citations
25 papers, 627 citations indexed

About

Dongmin Chang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dongmin Chang has authored 25 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Dongmin Chang's work include Epigenetics and DNA Methylation (5 papers), Ferroptosis and cancer prognosis (5 papers) and Cancer-related molecular mechanisms research (5 papers). Dongmin Chang is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Ferroptosis and cancer prognosis (5 papers) and Cancer-related molecular mechanisms research (5 papers). Dongmin Chang collaborates with scholars based in China, United States and South Korea. Dongmin Chang's co-authors include Wenhan Li, Qingnuo Zeng, Bin Hou, Yongchun Song, Xin Xie, Peng Xia, Zhangjian Zhou, Kun Guo, Tusheng Song and Bo Guo and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Carcinogenesis and Medicine.

In The Last Decade

Dongmin Chang

24 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongmin Chang China 13 393 260 184 71 69 25 627
Luísa Matos do Canto Brazil 15 286 0.7× 187 0.7× 214 1.2× 41 0.6× 61 0.9× 34 521
Lingmi Hou China 13 252 0.6× 172 0.7× 119 0.6× 56 0.8× 77 1.1× 44 487
Xiaojian Ni China 13 263 0.7× 185 0.7× 201 1.1× 54 0.8× 60 0.9× 34 475
Zhanhuai Wang China 12 231 0.6× 170 0.7× 243 1.3× 100 1.4× 68 1.0× 24 501
Deyuan Fu China 14 359 0.9× 326 1.3× 168 0.9× 45 0.6× 101 1.5× 35 614
Jinsong Wang China 13 387 1.0× 239 0.9× 120 0.7× 62 0.9× 93 1.3× 29 550
Jianfeng Sang China 12 459 1.2× 368 1.4× 130 0.7× 97 1.4× 62 0.9× 42 692
Fukun Chen China 14 332 0.8× 228 0.9× 125 0.7× 99 1.4× 111 1.6× 27 583
Chuanming Zheng China 16 245 0.6× 194 0.7× 194 1.1× 61 0.9× 108 1.6× 56 639
Margherita Puppo Italy 8 391 1.0× 279 1.1× 172 0.9× 34 0.5× 65 0.9× 11 605

Countries citing papers authored by Dongmin Chang

Since Specialization
Citations

This map shows the geographic impact of Dongmin Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongmin Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongmin Chang more than expected).

Fields of papers citing papers by Dongmin Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongmin Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongmin Chang. The network helps show where Dongmin Chang may publish in the future.

Co-authorship network of co-authors of Dongmin Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Dongmin Chang. A scholar is included among the top collaborators of Dongmin Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongmin Chang. Dongmin Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zeng, Qingnuo, et al.. (2024). Platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with gastric cancer undergoing radical resection. Frontiers in Oncology. 14. 1279011–1279011. 5 indexed citations
3.
Xu, Longwen, Mengjie Liu, Jie Lian, et al.. (2023). A prognostic nomogram for predicting recurrence-free survival of stage I–III colon cancer based on immune-infiltrating Treg-related genes. Journal of Cancer Research and Clinical Oncology. 149(15). 13523–13543.
4.
Zeng, Qingnuo, et al.. (2023). Glucose metabolism‐based signature predicts prognosis and immunotherapy strategies for colon adenocarcinoma. The Journal of Gene Medicine. 26(1). e3620–e3620. 2 indexed citations
5.
Chang, Dongmin, et al.. (2023). Prediction and therapeutic targeting of the tumor microenvironment-associated gene CTSK in gastric cancer. Discover Oncology. 14(1). 200–200. 3 indexed citations
6.
Guo, Kai, et al.. (2022). Does the LHPP gene share a common biological function in pancancer progression?. BMC Medical Genomics. 15(1). 239–239. 3 indexed citations
8.
Hou, Bin, Wenhan Li, Peng Xia, et al.. (2021). LHPP suppresses colorectal cancer cell migration and invasion in vitro and in vivo by inhibiting Smad3 phosphorylation in the TGF-β pathway. Cell Death Discovery. 7(1). 273–273. 39 indexed citations
10.
Li, Fei, Huimei Huang, & Dongmin Chang. (2020). Pivalopril improves anti-cancer efficiency of cDDP in breast cancer through inhibiting proliferation, angiogenesis and metastasis. Biochemical and Biophysical Research Communications. 533(4). 853–860. 7 indexed citations
11.
Hou, Bin, et al.. (2019). Efficiency of CAR-T Therapy for Treatment of Solid Tumor in Clinical Trials: A Meta-Analysis. Disease Markers. 2019. 1–11. 96 indexed citations
12.
Li, Wenhan, Yongchun Song, Ming Ni, et al.. (2018). Prognostic Role of Pretreatment Plasma D-Dimer in Patients with Solid Tumors: a Systematic Review and Meta-Analysis. Cellular Physiology and Biochemistry. 45(4). 1663–1676. 49 indexed citations
13.
Li, Wenhan, Yongchun Song, Hao Zhang, et al.. (2017). Decreased Expression of Hsa_circ_00001649 in Gastric Cancer and Its Clinical Significance. Disease Markers. 2017. 1–6. 102 indexed citations
14.
Liu, Changhong, Mo Li, Xuefei Zhang, et al.. (2017). Hypermethylation of miRNA-589 promoter leads to upregulation of HDAC5 which promotes malignancy in non-small cell lung cancer. International Journal of Oncology. 50(6). 2079–2090. 41 indexed citations
15.
Xia, Peng, Bin Li, Tingting Geng, et al.. (2015). FGFR2 gene polymorphisms are associated with breast cancer risk in the Han Chinese population.. PubMed Central. 5(5). 1854–61. 36 indexed citations
16.
Wang, Zhi, Chengxue Dang, Kun Zhu, et al.. (2015). Cyclophosphamide, epirubicin and fluorouracil chemotherapy-induced alteration of haemostasis markers in breast cancer patients. Molecular and Clinical Oncology. 3(5). 1088–1092. 6 indexed citations
17.
Chang, Dongmin, Jack A. Roth, Y. Ye, et al.. (2014). Genetic variants of the Wnt signaling pathway as predictors of recurrence and survival in early-stage non-small cell lung cancer patients. Carcinogenesis. 35(6). 1284–1291. 20 indexed citations
18.
Guo, Bo, Liying Liu, Jiayi Yao, et al.. (2013). miR-338-3p Suppresses Gastric Cancer Progression through a PTEN-AKT Axis by Targeting P-REX2a. Molecular Cancer Research. 12(3). 313–321. 74 indexed citations
19.
Guo, Bo, Jie Li, Liying Liu, et al.. (2013). Dysregulation of miRNAs and their potential as biomarkers for the diagnosis of gastric cancer. Biomedical Reports. 1(6). 907–912. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026